Protalix BioTherapeutics (PLX) Q1 2023 Earnings

4MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.18
-0.14
-0.09
-0.05

Details

Expected EPS
N/A
Actual EPS
-0.05
Surprise EPS
-0.05
Surprise Percent
+∞%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.05 per share for Q1 2023.

0 Comments

Share your thoughts